Peter M. Haverty, Ph.D.
Affiliations: | 2005 | Boston University, Boston, MA, United States |
Area:
Biostatistics Biology, Molecular BiologyGoogle:
"Peter Haverty"Mean distance: (not calculated yet)
Parents
Sign in to add mentorZhiping Weng | grad student | 2005 | Boston University | |
(Computational inference of transcriptional regulatory networks in eukaryotes.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Raisner R, Bainer R, Haverty PM, et al. (2020) Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. Plos One. 15: e0235343 |
Kong Y, Rose CM, Cass AA, et al. (2019) Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nature Communications. 10: 5228 |
Fortin JP, Tan J, Gascoigne KE, et al. (2019) Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens. Genome Biology. 20: 21 |
Lim YW, Chen-Harris H, Mayba O, et al. (2018) Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration. Proceedings of the National Academy of Sciences of the United States of America |
Raisner R, Kharbanda S, Jin L, et al. (2018) Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Reports. 24: 1722-1729 |
Wagle MC, Kirouac D, Klijn C, et al. (2018) A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types. Npj Precision Oncology. 2: 7 |
Merchant M, Moffat J, Schaefer G, et al. (2017) Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors. Plos One. 12: e0185862 |
Sahu N, Dela Cruz D, Gao M, et al. (2016) Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis. Cell Metabolism |
Haverty PM, Lin E, Tan J, et al. (2016) Reproducible pharmacogenomic profiling of cancer cell line panels. Nature. 533: 333-7 |
Wagle M, Klijn C, Liu B, et al. (2016) Abstract 417: A novel predictive biomarker model for MEK sensitivity Cancer Research. 76: 417-417 |